2014
Short and long-term safety and efficacy of polymer-free vs. durable polymer drug-eluting stents. A comprehensive meta-analysis of randomized trials including 6178 patients
Navarese EP, Kowalewski M, Cortese B, Kandzari D, Dias S, Wojakowski W, Buffon A, Lansky A, Angelini P, Torguson R, Kubica J, Kelm M, de Boer MJ, Waksman R, Suryapranata H. Short and long-term safety and efficacy of polymer-free vs. durable polymer drug-eluting stents. A comprehensive meta-analysis of randomized trials including 6178 patients. Atherosclerosis 2014, 233: 224-231. PMID: 24529148, DOI: 10.1016/j.atherosclerosis.2013.12.024.Peer-Reviewed Original ResearchConceptsDurable polymer drug-eluting stentsDrug-eluting stentsStent thrombosisPolymer-free drug-eluting stentsRandomized trialsMyocardial infarctionMain efficacy endpointLong-term safetyLesion revascularizationEfficacy endpointSafety endpointVessel revascularizationMI ratesLong followCochrane DatabaseSafety profileClinical practiceRCTsGoogle ScholarConflicting resultsRevascularizationSignificant differencesEfficacyPatientsEndpoint
2010
LONG-TERM SAFETY PROFILE OF XIENCE V EVEROLIMUS-ELUTING COMPARED TO TAXUS EXPRESS PACLITAXEL-ELUTING STENTS
Applegate R, Sudhir K, Hermiller J, Doostzadeh J, Yu S, Hattori K, Lansky A, Cutlip D, Simonton C, Stone G. LONG-TERM SAFETY PROFILE OF XIENCE V EVEROLIMUS-ELUTING COMPARED TO TAXUS EXPRESS PACLITAXEL-ELUTING STENTS. Journal Of The American College Of Cardiology 2010, 55: a126.e1180. DOI: 10.1016/s0735-1097(10)61181-3.Peer-Reviewed Original Research